FilingReader Intelligence
Eris Lifesciences quarterly profit jumps 40% to INR 125cr
August 5, 2025 at 07:59 AM UTC•By FilingReader AI
Eris Lifesciences reported consolidated net profit of INR 125.10 crores for the quarter ended June 30, up 40% from INR 89.55 crores a year earlier.
Revenue rose to INR 773.00 crores from INR 719.72 crores year-over-year. Basic earnings per share stood at INR 8.66 on a consolidated basis.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:ERIS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Eris Lifesciences publishes news
Free account required • Unsubscribe anytime